NorthWest Biotherapeutics Inc (NWBO)

[skitahoe]

Bob,

What exactly is TLD. I agree the company has all the data, but TLD is a statement from the company, normally a couple paragraphs, that summarizes the trial.

I believe this trial was exceptionally complex, it included a decision to change the primary goals, and with all that's happened in the trial, I think any attempt to describe what happened in a few paragraphs would be subject to all kinds of questions from shorts attempting to diminish what was said.

One of the big problems with putting out a TLD statement well in advance of peer reviewed data is that the company really can't answer the questions. Once peer reviewed information is presented, they can answer by citing what's been peer reviewed. Once again the company determined that a short presentation at a conference would still leave them open to questions which wouldn't be covered in that presentation. A presentation in a Journal was determined to be far more comprehensive, it will answer the greater majority of the issues the shorts could use in attempting to cast doubt.

With the decision to go with the Journal, the company also committed not to provide a TLD statement until that Journal is about to be out, perhaps they'll announce the date of the Journal when they make the TLD statement. For now, just accept what Dr. Liau and Ashkan has told everyone about people simply surviving longer than people would anticipate. If you don't like that, here's my minimalistic belief in what the TLD should say, The primary trial goal of overall survival has been met, or actually substantially exceeded. That's only one sentence, do you really need to know more than that.

Gary